Get alerts
Closed

Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)

Posted
May 11, 2026
Closed
June 10, 2026
Award ceiling
$500,000
Program funding
$4,500,000
Expected awards
3
Cost sharing
No
Instrument
Cooperative Agreement
Assistance listing
93.061
Category
Health
Archives
May 12, 2027

Program funding history

Awards made under Assistance Listing 93.061 across FY2024–FY2026, from public federal spending records.

FY2024 obligated
$0
FY2025 obligated
$0
FY2026 (to date) obligated
$0
Awards in window
15

No net new obligations were recorded under this listing in the window shown: downward adjustments to earlier awards offset or exceeded new awards in every year. Awards in window counts awards with at least one recorded transaction in the window, adjustments included.

Top recipients: Creare Llc, Dartmouth-hitchcock Clinic, Northwestern University, Aster Labs, Inc., Tria Bioscience Corp.

Source: USAspending.gov · refreshed September 2026

This opportunity is closed. Applications are no longer accepted. Similar grants are listed below, and the free Tuesday digest carries the next ones like it.

Synopsis

CDC/ATSDR is inviting research proposals to study risk factors for Amyotrophic Lateral Sclerosis (ALS). Studies on military service, contact sports, traumatic brain injury, neuroinflammation, and infections agents and exposures are encouraged. Funding will be for four funding options: Option A - Support research with strong existing evidence such as studies on known environmental or genetic risk factors, research that improves past studies with better data, or investigations linking risk factors to ALS diagnosis and treatment; Option B - Support new and exploratory research on ALS risk factors such as studies on risk factors with little existing evidence or research using innovative methods; Option C - Understand ALS risk in affected populations, such as studies involving military veterans or investigations of ALS risk factors impacting this population; Option D - Analyze biological samples from the Guamanian ALS cluster such as investigation of disease mechanisms and environmental factors, exposure routes, genetic studies and biomarkers and how this could lead to mitigation therapeutics, diagnostics or prevention.

Who can apply

Additional Eligibility Information to be included in the NOFO.

The official record

Grants.gov published the official terms and dates of this opportunity; this page keeps them as they were listed.

View on Grants.gov

Agency contact: Centers for Disease Control and Prevention - ERA · [email protected] · 404-498-2015

Tell me when this program posts again

This round has closed. One email the morning after this program is posted again under a new number (we watch for about two years), and one more about a week before that round closes (the next morning, if it is already closer than that). That is all this sends — it is not a newsletter signup.

Stored once per grant, used only for this watch’s emails; every one carries a one-click unsubscribe. Privacy

Get grants like this every Tuesday — free

One email a week: the biggest new federal grants and what’s closing soon — the same list for everyone. Unsubscribe any time.

No spam, ever. Privacy

Similar grants

Same-day alerts, matched to you

The free digest is weekly — the same list for everyone. Members get every open federal grant scored to their organization — and an alert the day a real match posts: we read every new posting the day it opens. Free for 30 days, then $29/mo. Card required, cancel any time before day 31.

Not ready for a subscription? A one-time Fit Report — $29 — scores every open federal grant to your organization once, by email within one business day.

See pricing